Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1995
[Structure-activity relation study of anti-herpes associations with a 2'-deoxyuridine basic structure]
P Herdewijn
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1992
[Development of new enzyme inhibitors for the treatment of AIDS[ ]
P Herdewijn
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Heterocyclic modifications of oligonucleotides and antisense technology
P Herdewijn
Biochimica Et Biophysica Acta
|
May 12, 2000
Conformationally restricted carbohydrate-modified nucleic acids and antisense technology
P Herdewijn
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1996
Antisense oligonucleotides
P Herdewijn
Current Topics in Medicinal Chemistry
|
August 14, 2002
RNA as a target for drug design, the example of Tat-TAR interaction
M Froeyen, P Herdewijn
Current Medicinal Chemistry
|
April 3, 2001
Selection of an unnatural peptide library for dsDNA binding
Z Zhang, P Herdewijn
FEBS Letters
|
June 20, 2012
Redesigning the leaving group in nucleic acid polymerization
P Herdewijn, P Marlière
Bioorganic & Medicinal Chemistry Letters
|
July 1, 1999
5-Substituted pyrimidine 1,5-anhydrohexitols: conformational analysis and interaction with viral thymidine kinase
J Wouters, P Herdewijn
Journal of Medicinal Chemistry
|
November 22, 1996
Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1
H De Winter, P Herdewijn
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1995
[Structure-activity relation study of anti-herpes associations with a 2'-deoxyuridine basic structure]
P Herdewijn
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1992
[Development of new enzyme inhibitors for the treatment of AIDS[ ]
P Herdewijn
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Heterocyclic modifications of oligonucleotides and antisense technology
P Herdewijn
Biochimica Et Biophysica Acta
|
May 12, 2000
Conformationally restricted carbohydrate-modified nucleic acids and antisense technology
P Herdewijn
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
January 1, 1996
Antisense oligonucleotides
P Herdewijn
Current Topics in Medicinal Chemistry
|
August 14, 2002
RNA as a target for drug design, the example of Tat-TAR interaction
M Froeyen, P Herdewijn
Current Medicinal Chemistry
|
April 3, 2001
Selection of an unnatural peptide library for dsDNA binding
Z Zhang, P Herdewijn
FEBS Letters
|
June 20, 2012
Redesigning the leaving group in nucleic acid polymerization
P Herdewijn, P Marlière
Bioorganic & Medicinal Chemistry Letters
|
July 1, 1999
5-Substituted pyrimidine 1,5-anhydrohexitols: conformational analysis and interaction with viral thymidine kinase
J Wouters, P Herdewijn
Journal of Medicinal Chemistry
|
November 22, 1996
Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1
H De Winter, P Herdewijn
Page
of 15